CA2430794A1 - Human genes and gene expression products isolated from human prostate - Google Patents

Human genes and gene expression products isolated from human prostate Download PDF

Info

Publication number
CA2430794A1
CA2430794A1 CA002430794A CA2430794A CA2430794A1 CA 2430794 A1 CA2430794 A1 CA 2430794A1 CA 002430794 A CA002430794 A CA 002430794A CA 2430794 A CA2430794 A CA 2430794A CA 2430794 A1 CA2430794 A1 CA 2430794A1
Authority
CA
Canada
Prior art keywords
sequence
seq
polynucleotide
nos
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002430794A
Other languages
English (en)
French (fr)
Inventor
Jaime Escobedo
Pablo Dominguez Garcia
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
William Lee Jones
Birgit Stache-Crain
Elizabeth M. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of CA2430794A1 publication Critical patent/CA2430794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002430794A 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate Abandoned CA2430794A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25464800P 2000-12-07 2000-12-07
US60/254,648 2000-12-07
US27568801P 2001-03-13 2001-03-13
US60/275,688 2001-03-13
PCT/US2001/047349 WO2002055700A2 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Publications (1)

Publication Number Publication Date
CA2430794A1 true CA2430794A1 (en) 2002-07-18

Family

ID=26944174

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002430794A Abandoned CA2430794A1 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Country Status (5)

Country Link
EP (1) EP1379651A2 (ja)
JP (1) JP2004526429A (ja)
AU (1) AU2002243300A1 (ja)
CA (1) CA2430794A1 (ja)
WO (1) WO2002055700A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
AU2002246708A1 (en) 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005080562A1 (ja) * 2004-02-23 2005-09-01 Hiroshi Yamamoto 前立腺癌の判定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Also Published As

Publication number Publication date
EP1379651A2 (en) 2004-01-14
WO2002055700A3 (en) 2003-10-23
JP2004526429A (ja) 2004-09-02
AU2002243300A1 (en) 2002-07-24
WO2002055700A2 (en) 2002-07-18
WO2002055700A8 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
US7122373B1 (en) Human genes and gene expression products V
US20070243176A1 (en) Human genes and gene expression products
JP2003518920A (ja) 新規なヒト遺伝子および遺伝子発現産物
WO2001066753A2 (en) Human genes and gene expression products
US20020076735A1 (en) Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells
US20110288034A1 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
US20030190640A1 (en) Genes expressed in prostate cancer
JP2002500010A (ja) ヒト遺伝子および遺伝子発現産物ｉ
JP2002519000A (ja) ヒト遺伝子および遺伝子発現産物ｉｉ
JP2007289196A (ja) 癌組織でディファレンシャルに発現される核酸配列
US20030215803A1 (en) Human genes and gene expression products isolated from human prostate
JP2011254830A (ja) 結腸癌に関するポリヌクレオチド
US20030065156A1 (en) Novel human genes and gene expression products I
CA2430794A1 (en) Human genes and gene expression products isolated from human prostate
WO2000018916A2 (en) Human genes and gene expression products
EP1268528A2 (en) Human genes and expression products
US20030104418A1 (en) Diagnostic markers for breast cancer
WO2004039943A2 (en) Human genes and gene expression products isolated from human prostate
WO2003103474A2 (en) Diagnostic markers for disorders of the nervous system

Legal Events

Date Code Title Description
FZDE Dead